Autopsy report · NCT06144827
A Pilot Study For Patients Receiving Radiation Therapy for Liver Cancer
Cause of deathStaffing, sites or logistics, also slow enrollment
“PI indicated that the site was unable to procure shunt. No participants were enrolled and this HepQuant study will be withdrawn.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- Montefiore Medical Center
- Sponsor type
- University, hospital or other
- Conditions
- Cancer, Hepatocellular; Radiotherapy Side Effect
- Interventions
- Multiparametric MRI scans; Multiparametric MRI scans + HepQuantShunt Test
- Participants
- 0
Trials that died the same way
- HIV-1 Vaccine Test in Uninfected Adult Volunteers
“The study product was revised. PI withdrew the study without enrolling participants..” - Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent
“Study did not accrue any participants, the PI has left the institution.” - Thoracic Kyphosis and Osteoporosis: Study of Their Relationship With Respiratory Functions in Chronic Obstructive Pulmonary Disease.
“The site is no more able to conduct the study” - Potential Benefits of Sleeve Gastrectomy Surgery on Diabetic Gastroparesis Symptoms
“No participants enrolled. Study terminated at PI's discretion” - Ozurdex Monotherapy Trial
“The study was withdrawn due to insufficient participant enrollment.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.